Rankings
▼
Calendar
FULC Q4 2021 Earnings — Fulcrum Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FULC
Fulcrum Therapeutics, Inc.
$436M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
+19.7% YoY
Gross Profit
-$14M
-273.9% margin
Operating Income
-$24M
-465.8% margin
Net Income
-$23M
-464.3% margin
EPS (Diluted)
$-0.58
QoQ Revenue Growth
+2.5%
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$22M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$235M
Total Liabilities
$23M
Stockholders' Equity
$212M
Cash & Equivalents
$35M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5M
$4M
+19.7%
Gross Profit
-$14M
-$12M
-16.2%
Operating Income
-$24M
-$18M
-32.5%
Net Income
-$23M
-$18M
-32.5%
← FY 2021
All Quarters
Q1 2022 →